Predictive Biomarker Testing in Lung Cancer (ALK, ROS1, PDL1, EGFR, KRAS, BRAF, MET and RET) Principle of Examination Non-Small Cell Lung Carcinomas (NSCLC) account for around 85% of lung cancers and includes predominantly adenocarcinoma and squamous cell carcinoma. Depending on the patients’ medical status and stage of disease, treatment options include surgery, radiation therapy and … Continue reading Predictive Biomarker Testing in Lung Cancer